You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions

 

Online download statistics by month:

Online download statistics by month: November 2022 to July 2025

AbstractFullPdf
Nov 2022502507195
Dec 202213413456
Jan 202312312440
Feb 2023979843
Mar 2023575722
Apr 2023666722
May 2023444523
Jun 2023525226
Jul 2023383827
Aug 2023414133
Sep 2023252533
Oct 2023222214
Nov 2023313120
Dec 2023393921
Jan 2024404223
Feb 2024292924
Mar 2024404125
Apr 2024383821
May 2024313120
Jun 2024343415
Jul 2024474821
Aug 2024242461
Sep 20244848210
Oct 20246565155
Nov 2024404125
Dec 2024313215
Jan 2025454528
Feb 2025313117
Mar 2025393939
Apr 2025616141
May 2025474723
Jun 2025303114
Jul 2025110
Total199220081352